Cipher Pharmaceuticals (OTCMKTS:CPHRF) Stock Price Passes Above Fifty Day Moving Average – What’s Next?

Shares of Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) (TSE:CPH) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $11.96 and traded as high as $13.6425. Cipher Pharmaceuticals shares last traded at $13.37, with a volume of 7,108 shares traded.

Cipher Pharmaceuticals Trading Down 4.9%

The firm has a 50-day moving average of $11.96 and a two-hundred day moving average of $11.04.

About Cipher Pharmaceuticals

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company that develops, acquires and commercializes prescription products in respiratory and dermatology markets. Founded in 2004 and headquartered in Vancouver, British Columbia, the company focuses on in-licensing established therapies and launching them under its own commercial infrastructure in North America.

In the respiratory segment, Cipher markets generic inhalation therapies for conditions such as asthma and chronic obstructive pulmonary disease (COPD).